Pediatric Neurology
Volume 28, Issue 3 , Pages 194-198 , March 2003

Prednisone therapy in pediatric epilepsy

  • D.Barry Sinclair, MD

      Affiliations

    • Comprehensive Epilepsy Program, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationCommunications should be addressed to: Dr. Sinclair; Director; Division of Pediatric Neurology; 2C3 Walter MacKenzie Health Sciences Centre; University of Alberta; Edmonton, AB, T6G 2B7, Canada

Received 11 April 2002 ,Accepted 26 August 2002.

References 

  1. Ito M, Okuno T, Fuji T, et al.  ACTH therapy in infantile spasms (Relationship between dose of ACTH and initial effect or long term prognosis). Pediatr Neurol. 1990;6:240–244
  2. Singer WD, Rabe EF, Haller TS. The effect of ACTH therapy upon infantile spasms. J Pediatr. 1980;96:485–489
  3. Lombroso CT. A prospective study of infantile spasms (Clinical and therapeutic correlations). Epilepsia. 1983;24:135–158
  4. Riikonen R, Donner M. ACTH therapy in infantile spasms (Side effects). Arch Dis Child. 1980;55:664–672
  5. Riikonen R. A long term follow up study of 214 children with the syndrome of infantile spasms. Neuropediatrics. 1982;13:14–23
  6. Hachovy RA, Kellawry P, Zion TE. Double blind study of ACTH vs. Prednisone therapy in infantile spasms. J Pediatr. 1983;103:641–645
  7. Baram TZ, Mitchell WG, Tourney A, Snead OC, Hanson RA, Horton EJ. High dose corticotrophin (ACTH) versus prednisone for infantile spasms. A prospective, randomized blinded study. Pediatrics. 1996;97:375–379
  8. Sher PK, Sheikh MR. Therapeutic efficacy of ACTH in symptomatic infantile spasms with hypsarrhythmia. Pediatr Neurol. 1993;9:451–456
  9. Bobele GB, Bodensteiner JB. The treatment of infantile spasms by child neurologists. J Child Neurol. 1994;9:432–435
  10. Hpachovy RA, Frost JD, Glaze DC. High-dose, long duration versus low-dose, short duration corticotropin therapy for infantile spasms. J Pediatr. 1994;124:803–806
  11. Riikonen R. Current knowledge of action of ACTH and corticosteroids. Brain Dev. 1987;9:409–414
  12. Snead OC, Benton JW, Myers GJ. ACTH and prednisone in childhood seizure disorders. Neurology. 1983;33:966–970
  13. Schmidt D. Diagnostic and therapeutic management of intractable epilepsy. In:  Schmidt D,  Morselli PL editor. Intractable epilepsy (Experimental and clinical aspects). New York: Raven Press; 1986;p. 237–257
  14. Aicardi J. Clinical approach to the management of intractable epilepsy. Dev Med Child Neurol. 1988;30:429–440
  15. Aicardi J. Diseases of the nervous system in childhood - 2nd ed. Cambridge: MacKeith Press; 1998;
  16. Aicardi J. Epilepsy in children. In:  Rapin I editors. The international review of child neurology. 2nd ed. New York: Raven Press; 1992;
  17. Prasad AN, Stafstrom CF, Holmes GC. Ahernatic epilepsy therapies (The ketogenic diet, immunoglobulins and steroids). Epilepsia. 1996;37(Suppl):589–595
  18. Yamatogi Y, Ohtsuka Y, Ishida T. Treatment of the Lennox-Gastaut syndrome with ACTH: A clinical and electroencephalographic study. Brain Dev 1979:267–76
  19. Schmidt D, Bourgeois B. A risk-benefit assessment of therapies for Lennox-Gastaut syndrome. Drug Saf. 2000;June 22:467–477
  20. Baram TZ. Pathophysiology of massive infantile spasm (Perspective on the putative role of the brain adrenal axis). Ann Neurol. 1993;33:231–236
  21. Baram TZ, Schultz L. ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia. 1995;36:174–178
  22. Joels M. Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol. 1997;18:2–48
  23. Beyenburg S, Stoffel-Wagner B, Bauer J, et al.  Neuroactive steroids and seizure susceptibility. Epilepsy Res. 2001;44:141–153
  24. Kokata TG, Cohen AL, Karp E, Rogawski MA. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharamacology. 1996;35:1049–1056
  25. Banerjee PK, Snead OC. Neuroactive steroids exacerbate gamma-hydroxybutric acid-induced absence seizures in rats. Eur J Pharmacol. 1998;359(1):41–48 16
  26. Fayad M, Choveiri R, Mikati M. Landau-Kleffner syndrome (Consistent response to repeated intravenous gamma-globulin doses: A case report). Epilepsia. 1997;38:488–494
  27. Connolly A, Chez M, Pestronk A, Arnold S, Mehta S, Devel R. Serum autoantibodies in Landau-Kleffner variant, autism and other neurological disorders. J Pediatr. 1999;134:607–613
  28. Van Rijckevorsel K, DeLire M. Immunological treatment in human and experimental epilepsy. J Neurol Neurosurg Psychiatry. 1995;59:115–127
  29. Illum N, Taudorf K, Heilman C, et al.  Intravenous immunoglobulin (A single-blind trial in children with Lennox-Gastaut syndrome). Neuropediatrics. 1990;21:87–90
  30. Ariizumi M, Shiihara H, Hibio S. High dose gammaglobulin for intractable childhood epilepsy. Lancet. 1983;2:162–163

PII: S0887-8994(02)00513-1

doi: 10.1016/S0887-8994(02)00513-1

Pediatric Neurology
Volume 28, Issue 3 , Pages 194-198 , March 2003

Article Tools

* Image Usage & Resolution